|
Volumn 25, Issue 4 SUPPL. 10, 1998, Pages 61-65
|
Efficacy of dexrazoxane as a cardioprotective agent in patients receiving mitoxantrone- and daunorubicin-based chemotherapy
a a
a
NONE
(Czech Republic)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTHRACYCLINE ANTIBIOTIC AGENT;
CYTARABINE;
DAUNORUBICIN;
DOXORUBICIN;
EPIRUBICIN;
MITOXANTRONE;
RAZOXANE;
REFADOR;
RUBOMYCIN;
UNCLASSIFIED DRUG;
ACUTE GRANULOCYTIC LEUKEMIA;
ADULT;
BONE MARROW TOXICITY;
CANCER INHIBITION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
FEMALE;
HEART PROTECTION;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
MALE;
NEUTROPENIA;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
REMISSION;
REVIEW;
ADULT;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARDIOVASCULAR AGENTS;
DAUNORUBICIN;
FEMALE;
HEART DISEASES;
HUMANS;
LEUKEMIA, MYELOCYTIC, ACUTE;
MALE;
MIDDLE AGED;
MITOXANTRONE;
RAZOXANE;
|
EID: 0031688723
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (16)
|
References (26)
|